Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A Retrospective Study Analyzing the Clinical Course of Patients with Non-Small Cell Lung Cancer Receiving Local or Systemic Therapy after Post-Operative Recurrence].
Inomata M, Tanaka H, Shimokawa K, Tokui K, Okazawa S, Taka C, Kambara K, Imanishi S, Yamada T, Miwa T, Hayashi R, Matsui S, Kashii T, Homma T, Nomura K, Doki Y, Tobe K. Inomata M, et al. Among authors: hayashi r. Gan To Kagaku Ryoho. 2017 Sep;44(9):767-770. Gan To Kagaku Ryoho. 2017. PMID: 28912406 Japanese.
Relationship between Patient Characteristics and the Timing of Provision of Explanation about DNAR to Patients with Advanced Lung Cancer.
Inomata M, Hirai T, Takata N, Murayama N, Hayashi K, Seto Z, Tokui K, Okazawa S, Kambara K, Imanishi S, Miwa T, Matsui S, Hayashi R, Tobe K. Inomata M, et al. Among authors: hayashi k, hayashi r. Intern Med. 2020 Dec 1;59(23):2989-2994. doi: 10.2169/internalmedicine.4704-20. Epub 2020 Aug 4. Intern Med. 2020. PMID: 32759584 Free PMC article.
Association of Tumor PD-L1 Expression With Time on Treatment Using EGFR-TKIs in Patients With EGFR-Mutant Non-small Cell Lung Cancer.
Inomata M, Matsumoto M, Mizushima I, Seto Z, Hayashi K, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Matsui S, Tobe K. Inomata M, et al. Among authors: hayashi k, hayashi r. Cancer Diagn Progn. 2022 May 3;2(3):324-329. doi: 10.21873/cdp.10112. eCollection 2022 May-Jun. Cancer Diagn Progn. 2022. PMID: 35530643 Free PMC article.
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.
Tsuda T, Ichikawa T, Matsumoto M, Mizusihima I, Azechi K, Takata N, Murayama N, Hayashi K, Hirai T, Seto Z, Tokui K, Masaki Y, Taka C, Okazawa S, Kambara K, Imanishi S, Taniguchi H, Miwa T, Hayashi R, Matsui S, Inomata M. Tsuda T, et al. Among authors: hayashi k, hayashi r. Discov Oncol. 2024 Aug 29;15(1):382. doi: 10.1007/s12672-024-01046-5. Discov Oncol. 2024. PMID: 39207576 Free PMC article.
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
Inomata M, Tsuda T, Ichikawa T, Matsumoto M, Mizushima I, Azechi K, Takata N, Murayama N, Hayashi K, Hirai T, Seto Z, Tokui K, Masaki Y, Taka C, Okazawa S, Kambara K, Imanishi S, Taniguchi H, Miwa T, Hayashi R, Matsui S, Tobe K. Inomata M, et al. Among authors: hayashi k, hayashi r. Thorac Cancer. 2023 Jun;14(17):1618-1623. doi: 10.1111/1759-7714.14907. Epub 2023 Apr 26. Thorac Cancer. 2023. PMID: 37101081 Free PMC article.
1,597 results